Clinical Trials Logo

Sensory Deficit clinical trials

View clinical trials related to Sensory Deficit.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05602233 Completed - Ankle Sprains Clinical Trials

The Effect of Balance Training Following STARS on Postural Control

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Chronic ankle instability (CAI) is defined as the symptoms continuing 12 months after the first sprain and the functional and/or mechanical instability reported by the individual. The number of researches that include a combined treatment approach that will affect both sensory and motor components in rehabilitation strategies applied for CAI is limited. The aim of this study is to isolated sensory, isolated motor and combined targeted approaches for the treatment of chronic ankle instability (CAI); to compare the effects on postural control, range of motion, function and kinesiophobia and to contribute to an effective approach related to the applicability of Sensory-Targeted Ankle Rehabilitation Strategies in the treatment of CAI.

NCT ID: NCT03995511 Completed - Sensory Deficit Clinical Trials

Neurosensory Deficit of Inferior Alveolar Nerve Following Mandibular Orthognathic Surgery.

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

This clinical study investigates the sensation deficit in the lower lip and chin area after surgical correction of lower jaw deformity. The primary null hypothesis is: Lower jaw osteotomy cause no sensory deficit in the inferior alveolar nerve. The secondary null hypothesis is: Concurrent genioplasty with sagittal split does not increase the risk of sensory deficit in the inferior alveolar nerve.

NCT ID: NCT03375216 Completed - Sensory Deficit Clinical Trials

Quantitative Sensory Testing in Chronic Pain Patients Undergoing Opioid Treatment and Opioid Tapering

Start date: December 22, 2017
Phase: N/A
Study type: Interventional

Few studies have used quantitative sensory tests to study the effect of chronic opioid treatment on sensation. The investigators will test chronic pain patients who are on different MEDDs, normal volunteers, and patients undergoing an opioid taper. This will be the first study to perform sensory testing on patients while undergoing an opioid taper on an outpatient basis.

NCT ID: NCT03350061 Completed - Amputation Clinical Trials

Prosthesis With Sensations

Start date: November 12, 2017
Phase: N/A
Study type: Interventional

Lower limb amputees suffer complete lack of sensory feedback of current available prostheses, which excludes the central nervous system from the correct sensory-motor integration. It causes serious problems as: falls due to unexpected perturbations, asymmetric walking, low mobility, higher power consumption, feeling the prosthesis as a foreign body, high cognitive burden, and phantom limb pain occurrence. Investigators will provide amputees with a prosthesis restoring sensory feedback and will assess its benefits on the users.

NCT ID: NCT03172767 Completed - Preterm Birth Clinical Trials

The Relationship Between School Readiness and Sensory Processing Disorder in Preterm Preschooler

Preterm
Start date: March 20, 2017
Phase:
Study type: Observational [Patient Registry]

The study aims investigate sensory processing disorders and school readiness in pre-school preterm children and the relationship between sensory impairment and school readiness

NCT ID: NCT01758497 Completed - Sensory Deficit Clinical Trials

Fascia Iliaca Compartment Block For Analgesia After Total Hip Arthroplasty

FICB
Start date: October 2010
Phase: N/A
Study type: Interventional

Introduction Fascia Iliaca compartment block (FICB) is commonly used to treat pain in patients after total hip arthroplasty (THA) despite the lack of RCTs to evaluate the efficacy of FICB for this indication. Therefore the objective of this study was to assess the analgesic benefit of FICB for post-operative pain management in THA. Methods After IRB approval and informed consent, patients having THA at our center in the period 2010-2011 were recruited. Eligible patients were adults, ASA physical status I-III, and BMI <30) with no contraindication to study procedures. In the PACU, all patients received morphine sulfate IVPCA; patients reporting pain > 3 on the NRS-11 despite IVPCA were randomized by the method of sealed envelopes to receive US guided injections of 30ml 0.5% ropivacaine (FICB) or 30ml 0.9% NaCl (sham block, SB) beneath the fascia iliaca. The primary outcome variable was opioid analgesic consumption during the first 24 h postoperatively. Secondary outcome measures were pain intensity (NRS-11) and extent of sensory blockade.